Whitehawk Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Whitehawk Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- WHWK
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001422142
Board of directors
-
Anupam Dalal · DirectorSince 2023
-
Baiteng Zhao · DirectorSince 2024
-
Behzad Aghazadeh · DirectorSince 2023
-
Brendan Delaney · Director · See remarksSince 2023
-
Caley Castelein · DirectorSince 2023
-
David James Lennon · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Emma Reeve · DirectorSince 2023
-
Karin M. Hehenberger · DirectorSince 2023
-
Mohammad Hirmand · DirectorSince 2023
-
Neil Desai · Director · EXECUTIVE CHAIRMANSince 2023
-
Richard E. Maroun · DirectorSince 2023
Chief executives
David James Lennon
· Chief Executive Officer
Since October 2023
Board connections
3 of this board's directors also sit on 4 other boards.
- via Brendan Delaney
- via Emma Reeve
- via Emma Reeve
- via Behzad Aghazadeh
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,584,564
- 14 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 2026 | Margaret Dugan Officer (Chief Medical Officer) | Grant or award | +19,132 | $3.92 | $74,997 |
| May 14, 2026 | BALL BRYAN Officer (See remarks) | Grant or award | +51,020 | $3.92 | $199,998 |
| May 14, 2026 | Giacobello Scott M. Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +38,265 | $3.92 | $149,999 |
| May 14, 2026 | David James Lennon Director, Officer (CHIEF EXECUTIVE OFFICER) | Grant or award | +51,021 | $3.92 | $200,002 |
| May 14, 2026 | Caley Castelein Director | Grant or award | +255,102 | $3.92 | $1,000,000 |
| May 14, 2026 | Anupam Dalal Director | Grant or award | +1,275,510 | $3.92 | $4,999,999 |
| Apr 16, 2026 | Giacobello Scott M. Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | −141,600 | $4.13 | $584,808 |
| Apr 15, 2026 | Giacobello Scott M. Officer (CHIEF FINANCIAL OFFICER) | Open-market sale | −77,000 | $3.86 | $297,220 |
| Apr 14, 2026 | BALL BRYAN Officer (See remarks) | Open-market sale | −92,460 | $3.64 | $336,554 |
| Apr 13, 2026 | BALL BRYAN Officer (See remarks) | Open-market sale | −26,389 | $3.46 | $91,306 |
| Apr 10, 2026 | BALL BRYAN Officer (See remarks) | Open-market sale | −6,596 | $3.43 | $22,624 |
| Apr 9, 2026 | BALL BRYAN Officer (See remarks) | Open-market sale | −50,000 | $3.57 | $178,500 |
| Apr 9, 2026 | David James Lennon Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market sale | −14,500 | $3.38 | $49,010 |
| Apr 8, 2026 | David James Lennon Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market sale | −63,945 | $3.40 | $217,413 |
| Apr 7, 2026 | David James Lennon Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market sale | −94,087 | $3.43 | $322,718 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.